Biomerica, Inc. (BMRA)
2.23
-0.11
(-4.70%)
USD |
NASDAQ |
Sep 09, 15:07
Biomerica Debt to Equity Ratio : 0.9061 for May 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| May 31, 2026 | 0.9061 |
| February 28, 2026 | 0.0582 |
| November 30, 2025 | 0.064 |
| August 31, 2025 | 0.0724 |
| May 31, 2025 | 0.1116 |
| February 28, 2025 | 0.0981 |
| November 30, 2024 | 0.1224 |
| August 31, 2024 | 0.1322 |
| May 31, 2024 | 0.1191 |
| February 29, 2024 | 0.1104 |
| November 30, 2023 | 0.0999 |
| August 31, 2023 | 0.0939 |
| May 31, 2023 | 0.0923 |
| February 28, 2023 | 0.1969 |
| November 30, 2022 | 0.1724 |
| August 31, 2022 | 0.158 |
| May 31, 2022 | 0.1657 |
| February 28, 2022 | 0.1479 |
| November 30, 2021 | 0.1688 |
| August 31, 2021 | 0.1777 |
| May 31, 2021 | 0.1755 |
| February 28, 2021 | 0.1533 |
| November 30, 2020 | 0.1506 |
| August 31, 2020 | 0.1376 |
| May 31, 2020 | 0.1253 |
| Date | Value |
|---|---|
| February 29, 2020 | 0.3136 |
| November 30, 2019 | 0.5565 |
| August 31, 2019 | 0.5316 |
| May 31, 2019 | 0.00 |
| February 28, 2019 | 0.00 |
| November 30, 2018 | 0.00 |
| August 31, 2018 | 0.00 |
| May 31, 2018 | 0.00 |
| February 28, 2018 | 0.00 |
| November 30, 2017 | 0.00 |
| August 31, 2017 | 0.00 |
| May 31, 2017 | 0.00 |
| February 28, 2017 | 0.00 |
| November 30, 2016 | 0.00 |
| August 31, 2016 | 0.00 |
| May 31, 2016 | 0.00 |
| February 29, 2016 | 0.00 |
| November 30, 2015 | 0.00 |
| August 31, 2015 | 0.00 |
| May 31, 2015 | 0.00 |
| February 28, 2015 | 0.00 |
| November 30, 2014 | 0.00 |
| August 31, 2014 | 0.00 |
| May 31, 2014 | 0.00 |
| February 28, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Abbott Laboratories | 0.638 |
| Align Technology, Inc. | 0.0286 |
| AngioDynamics, Inc. | 0.0641 |
| Accuray, Inc. | 4.502 |
| Alphatec Holdings, Inc. | 52.37 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 6.759M |
| Total Liabilities (Quarterly) | 4.129M |
| Shareholders Equity (Quarterly) | 2.63M |
| Current Ratio | 1.619 |
| Net Debt Paydown Yield | -4.82% |